# Sofinnova Partners: portfolio, investments and team

> Sofinnova Partners is a vc firm based in France. 232 investments on record, 31 in the last 12 months, latest Oct 2026. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/sofinnova-partners (Millionrounds; every figure on the page links to its filing or article)

France · [Investor](https://millionrounds.com/investors)

# Sofinnova Partners

Last cheque observed Oct 2026; 232 cheques on record.

Email

Deploying now New fund $54M, Nov 2024 VC firm

Pre-seed Seed Series A Bio Digital-health Life Science

Follow Sofinnova Partners and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fsofinnova-partners)

Deploying now

**91%** of best year **31** **cheques in 12 months**, 232 on record

Since the last cheque **3** days **00** hrs **00** min **00** sec

Median round **$34M** Cheque size, as they say **$1.0M – $60M** Rounds led **13 of 232** Sole investor **23 rounds** Exits **17 from the portfolio** Mostly in **France, 32%**

Pitch Sofinnova Partners

## Sofinnova Partners highlights

- 01 31 cheques in the last 12 months
- 02 Mostly Series A and Series B: 59% of its rounds
- 03 Sole investor in 23 rounds, median $5.4M
- 04 17 exits from the portfolio

## What they do

> Sofinnova Partners invests in life sciences innovation worldwide, from biopharma and medtech to digital medicine and industrial biotech. From their own website

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** $1.0M – $60M as they say
- **Stages:** Pre-seed Seed Series A Series B Growth Pre-IPO
- **Sectors:** Bio Digital-health Life Science
- **Based in:** Paris, France
- **Cold pitches:** Accepted

## The record

Every round we can evidence, newest first **232 appearances**

- **2026** 24 rounds
- **Oct** **[DMC Biotechnologies](https://millionrounds.com/company/dmc-biotechnologies)** US · Capricorn Partners **$18M** *Led*
- **Oct** **[IMIO](https://millionrounds.com/company/imio)** Seed · US · AgFunderNews **$12M** *Led*
- **Sept** **[HighLife](https://millionrounds.com/company/highlife)** Growth · Capricorn Partners **$90M** *Led*
- **Sept** **[Neurent Medical](https://millionrounds.com/company/neurent-medical)** Debt · IE · Claret Capital Partners **$29M** With 6 others
- **Sept** **[One Biosciences](https://millionrounds.com/company/one-biosciences)** Grant · FR **$3.8M** With 3 others
- **Sept** **[EnginZyme](https://millionrounds.com/company/enginzyme)** Venture · SE **$7.6M** With 3 others
- **Aug** **[Mironid](https://millionrounds.com/company/mironid)** Series B · GB **$46M** With 1 other
- **Jun** **[Bionyra Pharma](https://millionrounds.com/company/bionyra-pharma)** Series A · FR · Ventureburn **$165M** *Led*
- **Jun** **[TISSIUM](https://millionrounds.com/company/tissium)** Series D · FR **$34M** With 4 others
- **Jun** **[Ingenix](https://millionrounds.com/company/ingenix)** Seed · PL **$15M** With 1 other
- **Jun** **[ProQR Therapeutics](https://millionrounds.com/company/proqr-therapeutics)** NL **$59M** With 1 other
- **Jun** **[Inventiva Pharma](https://millionrounds.com/company/inventiva-pharma)** FR **$120M** With 4 others
- **May** **[Signadori Bio](https://millionrounds.com/company/signadori-bio)** Seed · FR · Ventureburn **$13M** With 3 others
- **May** **[CellCentric](https://millionrounds.com/company/cellcentric)** Growth · Ventureburn **$220M** With 6 others
- **May** **[P2 Science](https://millionrounds.com/company/p2-science)** US · Firms' own news pages **$23M** With 9 others
- **May** **[Abivax](https://millionrounds.com/company/abivax)** FR **$45M** With 4 others
- **Apr** **[AFYREN](https://millionrounds.com/company/afyren)** Grant · FR **$3.5M** With 2 others
- **Mar** **[GenSight Biologics](https://millionrounds.com/company/gensight-biologics)** FR **$2.0M** With 4 others
- **Feb** **[Bon Vivant](https://millionrounds.com/company/bon-vivant)** Series A · FR **$29M** With 4 others
- **Jan** **[Mediar Therapeutics](https://millionrounds.com/company/mediar-therapeutics)** Series B · US **$76M** With 2 others
- **Jan** **[Tenpoint Therapeutics](https://millionrounds.com/company/tenpoint-therapeutics)** Debt · GB **$150M** With 4 others
- **Jan** **[BrightHeart](https://millionrounds.com/company/brightheart)** Series A · FR **$13M** With 1 other
- **Jan** **[Muna Therapeutics](https://millionrounds.com/company/muna-therapeutics)** Grant · DK **$1.0M** With 3 others
- **Jan** **[ProQR Therapeutics](https://millionrounds.com/company/proqr-therapeutics)** Grant · NL **$9.2M** With 1 other
- **2025** 26 rounds
- **Dec** **[Excelsior Sciences](https://millionrounds.com/company/excelsior-sciences)** Series A · US · AlleyWatch **$70M** *Led*
- **Dec** **[DISCO Pharmaceuticals](https://millionrounds.com/company/disco-pharmaceuticals)** Seed · DE **$42M** With 1 other
- **Nov** **[T-Therapeutics](https://millionrounds.com/company/t-therapeutics)** Series A · GB · Silicon Canals **$32M** With 4 others
- **Nov** **[myTomorrows](https://millionrounds.com/company/mytomorrows)** Growth · NL · Avego Management **$29M** With 5 others
- **Nov** **[Qorium](https://millionrounds.com/company/qorium)** Series A · NL · Silicon Canals **$25M** With 3 others
- **Nov** **[AAVantgarde Bio](https://millionrounds.com/company/aavantgarde-bio)** Series B · IT **$141M** With 3 others
- **Nov** **[Artios Pharma](https://millionrounds.com/company/artios-pharma)** Series D · GB **$115M** With 5 others
- **Oct** **[NanoPhoria](https://millionrounds.com/company/nanophoria)** Series A · IT **$98M** With 2 others
- **Oct** **[AFYREN](https://millionrounds.com/company/afyren)** FR **$27M** With 1 other
- **Oct** **[Hemab](https://millionrounds.com/company/hemab)** Series C · DK **$157M** With 3 others
- **Oct** **[Elevara Medicine](https://millionrounds.com/company/elevara-medicine)** Series A · GB **$70M** With 1 other
- **Oct** **[MISSION Therapeutics](https://millionrounds.com/company/mission-therapeutics)** Venture · GB **$13M** With 3 others
- **Sept** **[Galvanize Therapeutics, Inc](https://millionrounds.com/company/galvanize-therapeutics-inc)** Series C · US · Elevage Medical Technologies **$100M** *Led*
- **Sept** **[HAYA Therapeutics](https://millionrounds.com/company/haya-therapeutics)** Venture · CH **Undisclosed** With 4 others
- **Jul** **[Actithera](https://millionrounds.com/company/actithera)** Series A · GB · 4BIO Capital **$76M** *Led*
- **Jul** **[Abivax](https://millionrounds.com/company/abivax)** FR **$748M** With 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **6 named**

AP **Antoine Papiernik** Managing Partner and Chairman i Form ADV

CB **Christophe Blanche** Director of General Partner i Filing they signed

GS **Graziano Seghezzi** Managing Partner of AIFM i Filing they signed

HR **Henrijette Richter** Managing Partner of AIFM i Filing they signed

MK **Mats Kristian Eklund** Chief Operating Officer and Directeur General i Form ADV

QL **Quentin Leveque** Director of General Partner i Filing they signed

We also hold **88** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**$1.9B** gross assets of its funds Oct 2026

**Exempt** reporting adviser venture or small private funds

- **Legal name:** Sofinnova Partners SAS
- **SEC number:** CRD 164104

## Exits from the portfolio

Companies it backed that were later bought or listed **17 in all**

**[GlycoVaxyn](https://millionrounds.com/company/glycovaxyn)** Bought by [GSK Venture Fund](https://millionrounds.com/fund/gsk-venture-fund) **$190M** Feb 2015

**[mydeco](https://millionrounds.com/company/mydeco)** Bought by MONOQI **Undisclosed** Jan 2015

**[Omthera Pharmaceuticals](https://millionrounds.com/company/omthera-pharmaceuticals)** Bought by [AstraZeneca](https://millionrounds.com/fund/astrazeneca) **$443M** May 2013

**[BioAmber](https://millionrounds.com/company/bioamber)** Listed **$80M** May 2013

**[blueKiwi](https://millionrounds.com/company/bluekiwi)** Bought by Atos **Undisclosed** Apr 2012

**[Laszlo Systems](https://millionrounds.com/company/laszlo-systems)** Bought by Critical Path Inc. **Undisclosed** Feb 2012

**[PregLem](https://millionrounds.com/company/preglem)** Bought by [Richter Group](https://millionrounds.com/fund/richter-group) **Undisclosed** Oct 2010

**[UPEK](https://millionrounds.com/company/upek)** Bought by AuthenTec **Undisclosed** Sept 2010

**[Movetis](https://millionrounds.com/company/movetis)** Bought by [Shire](https://millionrounds.com/fund/shire) **$565M** Aug 2010

**[Streamezzo](https://millionrounds.com/company/streamezzo)** Bought by [Amdocs](https://millionrounds.com/fund/amdocs-ventures) **Undisclosed** Apr 2010

**[Sensitive Object](https://millionrounds.com/company/sensitive-object)** Bought by Tyco Electronics **$62M** Jan 2010

**[Fovea Pharmaceuticals](https://millionrounds.com/company/fovea-pharmaceuticals)** Bought by [Sanofi Aventis](https://millionrounds.com/fund/sanofi) **Undisclosed** Oct 2009

**[Purple Labs](https://millionrounds.com/company/purple-labs)** Bought by [Myriad](https://millionrounds.com/fund/myriad) **$101M** Feb 2009

**[Biolipox](https://millionrounds.com/company/biolipox)** Bought by Orexo **Undisclosed** Nov 2007

**[Ablynx](https://millionrounds.com/company/ablynx)** Listed **Undisclosed** Nov 2007

**[EnvoyWorldWide](https://millionrounds.com/company/envoyworldwide)** Bought by Varolii **Undisclosed** Dec 2005

**[Avaki](https://millionrounds.com/company/avaki)** Bought by [Sybase](https://millionrounds.com/fund/sybase) **Undisclosed** Aug 2005

An exit counts when it came after the firm's first round in the company. From historical deal records.

New fund on file

**$54M**

raised in Nov 2024

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Pre-seed Seed Series A

Median round joined **$34M** the round, not its cheque Alone, median **$5.4M**

Led 13 of 232 rounds **6%**

- **Said size:** $1.0M – $60M
- **Sole investor:** 23 rounds
- **Last cheque:** Oct 2026
- **Exits:** 17 from the portfolio

Rounds by stage said on their site

- Series A said *70*
- Series B said *44*
- Series C *32*
- Venture *29*
- Seed said *17*
- Pre-seed said *-*
- Growth said *-*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [Bpifrance](https://millionrounds.com/fund/bpifrance) 25
- [Gimv](https://millionrounds.com/fund/gimv) 12
- [Forbion Capital Partners](https://millionrounds.com/fund/forbion-capital-partners) 9
- [Capricorn Partners](https://millionrounds.com/fund/capricorn-partners) 8
- [Eli Lilly](https://millionrounds.com/fund/eli-lilly) 8
- [Novo Holdings](https://millionrounds.com/fund/novo-ventures) 8

**Pitching Sofinnova Partners?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Sofinnova Partners. A count of rooms they were both in, not a relationship either has claimed.

[**Bpifrance** Government **25** rounds together](https://millionrounds.com/fund/bpifrance)[**Gimv** Private equity **12** rounds together](https://millionrounds.com/fund/gimv)[**Forbion Capital Partners** Private equity **9** rounds together](https://millionrounds.com/fund/forbion-capital-partners)[**Capricorn Partners** VC firm **8** rounds together](https://millionrounds.com/fund/capricorn-partners)[**Eli Lilly** Corporate VC **8** rounds together](https://millionrounds.com/fund/eli-lilly)[**Novo Holdings** VC firm **8** rounds together](https://millionrounds.com/fund/novo-ventures)[**Andera Partners** Private equity **7** rounds together](https://millionrounds.com/fund/andera-partners)[**Auriga Partners** VC firm **7** rounds together](https://millionrounds.com/fund/auriga-partners)[**Redmile Group** VC firm **7** rounds together](https://millionrounds.com/fund/redmile-group)[**SR One** Corporate VC **7** rounds together](https://millionrounds.com/fund/sr-one)[**EQT Life Sciences** VC firm **6** rounds together](https://millionrounds.com/fund/eqt-life-sciences)[**5AM Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/5am-ventures)

## Recently backed

The latest companies Sofinnova Partners put money into.

[**DMC Biotechnologies** $18M · Oct 2026](https://millionrounds.com/company/dmc-biotechnologies)[**IMIO** $12M · Oct 2026](https://millionrounds.com/company/imio)[**HighLife** $90M · Sept 2026](https://millionrounds.com/company/highlife)[**Neurent Medical** $29M · Sept 2026](https://millionrounds.com/company/neurent-medical)[**One Biosciences** $3.8M · Sept 2026](https://millionrounds.com/company/one-biosciences)[**EnginZyme** $7.6M · Sept 2026](https://millionrounds.com/company/enginzyme)

## Quick answers about Sofinnova Partners

### What does Sofinnova Partners invest in?

Sofinnova Partners invests most often at Series A and Series B (59% of the rounds on record), in sectors such as Bio, Digital-health and Life Science.

### How active is Sofinnova Partners?

232 investments on record, 31 of them in the last 12 months, and it led 13. The most recent was in Oct 2026.

### What has Sofinnova Partners invested in recently?

Its most recent investments on record: DMC Biotechnologies (Oct 2026), IMIO (Seed, Oct 2026) and HighLife (Growth, Sept 2026).

### How big are Sofinnova Partners's cheques?

The median round it joins is $34M. It says it writes cheques of $1.0M to $60M.

### Does Sofinnova Partners lead rounds?

Sometimes: it led 13 of its 232 investments on record (6%).

### Where does Sofinnova Partners invest?

Most of the companies it backs are in France (32%), the United Kingdom (18%) and the United States (16%).

### Is Sofinnova Partners investing now?

Yes: it is actively investing, with 31 investments in the last 12 months.

### Who does Sofinnova Partners invest alongside?

Most often Bpifrance (25 rounds together), Gimv (12 rounds together) and Forbion Capital Partners (9 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=sofinnova-partners) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=sofinnova-partners)